Phase II study of erlotinib as a salvage treatment for non-small-cell lung cancer patients after failure of gefitinib treatment

Title
Phase II study of erlotinib as a salvage treatment for non-small-cell lung cancer patients after failure of gefitinib treatment
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 19, Issue 12, Pages 2039-2042
Publisher
Oxford University Press (OUP)
Online
2008-07-22
DOI
10.1093/annonc/mdn423

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started